Insider transactions

EDGAR

Opus Genetics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
2 transactions, 164,000 shares
Sum of shares × price per share: 323,693.4
Open-market sales (code S)
24 transactions, 6,476,531 shares
Sum of shares × price per share: 19,675,663.32

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 53

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-03 Filed 2026-11-05Magrath George Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)28,2583.8992
110,183.5936

Derived: shares × price per share. Exact value 110183.5936.

2,010,636Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $3.89 to $3.935, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001140361-26-042102 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Magrath George Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,5913.585
34,383.735

Derived: shares × price per share. Exact value 34383.735.

2,038,894Direct (D) No
F1
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.
Open filing 0001140361-26-040893 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27SCHACHLE JOSEPH K Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,7673.565
16,994.355

Derived: shares × price per share. Exact value 16994.355.

286,673Direct (D) No
F1
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.
Open filing 0001140361-26-040908 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27YERXA BENJAMIN R Director · Officer: President
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,6693.5514
27,235.6866

Derived: shares × price per share. Exact value 27235.6866.

696,437Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $3.5500 to $3.5522, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001140361-26-040906 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27YERXA BENJAMIN R Director · Officer: President
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,5203.5317
90,128.984

Derived: shares × price per share. Exact value 90128.9840.

670,917Direct (D) No
F1, F3
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.
  • F3 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $3.53 to $3.545, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001140361-26-040906 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-27Gagnon Robert E. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)14,0003.5464
49,649.6

Derived: shares × price per share. Exact value 49649.6000.

542,375Direct (D) Yes
F1, F2
  • F1 The shares reported on this line were sold were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 30, 2026. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Issuer. The shares sold cover tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $3.4449 to $3.79, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001140361-26-040896 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Foundation Fighting Blindness Retinal Degeneration Fund Director · Other: See RemarksFoundation Fighting Blindness, Inc. Director · Other: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)556,0004.9568
2,755,980.8

Derived: shares × price per share. Exact value 2755980.8000.

3,236,171Direct (D) No
F1, F2
  • F1 This transaction was executed in multiple trades at prices ranging from $4.95 to $5.29. The price reported in Column 4 is a weighted average price. The Reporting Persons hereby undertake to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  • F2 Foundation Fighting Blindness, Inc. (FFB) is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (RDF) and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold.
Open filing 0002042266-26-000002 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-11Magrath George Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)392,1571.15
450,980.55

Derived: shares × price per share. Exact value 450980.55.

2,124,026Direct (D) No— Open filing 0001140361-26-036347 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-11Magrath George Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)75,5415.97
450,979.77

Derived: shares × price per share. Exact value 450979.77.

2,048,485Direct (D) No
F1
  • F1 The Reporting Person paid the exercise price of the Warrant on a cashless basis. The Issuer withheld 75,541 shares, calculated in accordance with the terms of the Warrant, to pay the exercise price and issued the remaining 316,616 shares to the Reporting Person.
Open filing 0001140361-26-036347 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-11Magrath George Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Warrant (right to buy) — underlying Common Stock (392,157) — exercise price 1.15
Disposed (D)392,1570—0Direct (D) No
F2
  • F2 The Warrant was immediately exercisable upon its acquisition on March 24, 2025, subject to the Issuer's right to call the Warrant at any time beginning 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's Common Stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day.
Open filing 0001140361-26-036347 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-08Gallagher Cam Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)784,3141.15
901,961.1

Derived: shares × price per share. Exact value 901961.10.

2,800,111Direct (D) No
F1
  • F1 In conjunction with the exercise of the Warrant reported herein, the Reporting Person entered into a Lock-Up Agreement with the Issuer dated September 6, 2026 (the Lock-Up Agreement). Pursuant to the Lock-Up Agreement, among other terms, the Reporting Person agreed that, without the prior written consent of the Issuer, during the period beginning on September 6, 2026 and ending at the close of business 180 days after the issuance of the shares of Common Stock underlying the Warrant, the Reporting Person will not transfer or dispose of, directly or indirectly, any shares of Common Stock, or any securities convertible into or exercisable or exchangeable for Common Stock (including, without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the Reporting Person and securities which may be issued upon exercise of a stock option or warrant), as further described in the Lock-Up Agreement and subject to certain exclusions described therein.
Open filing 0001140361-26-035913 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-08Gallagher Cam Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Warrant (right to buy) — underlying Common Stock (784,314) — exercise price 1.15
Disposed (D)784,3140—0Direct (D) No
F3
  • F3 The Warrant was immediately exercisable upon its acquisition on March 24, 2025, subject to the Issuer's right to call the Warrant at any time beginning 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's Common Stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day.
Open filing 0001140361-26-035913 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-08Gagnon Robert E. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)28,0004.5433
127,212.4

Derived: shares × price per share. Exact value 127212.4000.

556,375Direct (D) No
F1, F2
  • F1 A portion of the shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer, to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units, and the remainder of the shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 30, 2026. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Issuer.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $4.29 to $4.79, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001140361-26-035912 Read from the filing’s XML Dispute this row
2026-07-23 Filed 2026-07-27Magrath George Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,4752.9473
27,925.6675

Derived: shares × price per share. Exact value 27925.6675.

1,731,869Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $2.9009 to $3.025, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0000905148-26-003352 Read from the filing’s XML Dispute this row
2026-07-23 Filed 2026-07-27Gagnon Robert E. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,7832.9477
22,941.9491

Derived: shares × price per share. Exact value 22941.9491.

584,375Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $2.9006 to $3.025, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0000905148-26-003351 Read from the filing’s XML Dispute this row
2026-07-23 Filed 2026-07-27YERXA BENJAMIN R Director · Officer: President
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,4292.97
22,064.13

Derived: shares × price per share. Exact value 22064.13.

704,106Direct (D) No
F1
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
Open filing 0000905148-26-003354 Read from the filing’s XML Dispute this row
2026-07-23 Filed 2026-07-27SCHACHLE JOSEPH K Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,6442.94
13,653.36

Derived: shares × price per share. Exact value 13653.36.

291,440Direct (D) No
F1
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
Open filing 0000905148-26-003353 Read from the filing’s XML Dispute this row
2026-05-18 Filed 2026-05-20Foundation Fighting Blindness Retinal Degeneration Fund Director · Other: See RemarksFoundation Fighting Blindness, Inc. Director · Other: See Remarks
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,700,0004.35
7,395,000

Derived: shares × price per share. Exact value 7395000.00.

3,792,171Direct (D) No
F1
  • F1 Foundation Fighting Blindness, Inc. (FFB) is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund (RDF) and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold.
Open filing 0002042266-26-000001 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,6415.204
8,539.764

Derived: shares × price per share. Exact value 8539.764.

188,671Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2038 to $5.2051, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0000905148-26-001865 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Magrath George Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,5115.22
49,647.42

Derived: shares × price per share. Exact value 49647.42.

1,741,344Direct (D) No
F1
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
Open filing 0000905148-26-001864 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Gagnon Robert E. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,8425.1846
40,657.6332

Derived: shares × price per share. Exact value 40657.6332.

592,158Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.1828 to $5.1901, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0000905148-26-001862 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27YERXA BENJAMIN R Director · Officer: President
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,4705.2371
39,121.137

Derived: shares × price per share. Exact value 39121.1370.

711,535Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2314 to $5.2413, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0000905148-26-001867 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27SCHACHLE JOSEPH K Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,6975.2202
24,519.2794

Derived: shares × price per share. Exact value 24519.2794.

296,084Direct (D) No
F1
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
Open filing 0000905148-26-001866 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc.
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,5425.1917
39,155.8014

Derived: shares × price per share. Exact value 39155.8014.

509,233Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.18 to $5.21, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0000905148-26-001863 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-04-22Graves Adrienne L Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)24,3670—127,514Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
Open filing 0000905148-26-001786 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-04-22Bennett Jean Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)24,3670—259,019Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
Open filing 0000905148-26-001782 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-04-22Rodgers Richard J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)24,3670—343,022Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
Open filing 0000905148-26-001788 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-04-22Gallagher Cam Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)24,3670—2,015,797Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
Open filing 0000905148-26-001785 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-04-22MANUSO JAMES S J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)24,3670—317,318Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
Open filing 0000905148-26-001787 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-04-22Benton Susan Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)24,3670—243,894Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
Open filing 0000905148-26-001784 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-04-22Ainsworth Sean Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)24,3670—321,692Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date.
Open filing 0000905148-26-001781 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Magrath George Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)24,4385.2102
127,326.8676

Derived: shares × price per share. Exact value 127326.8676.

1,750,855Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.21 to $5.215, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0000905148-26-001381 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc.
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,7195.1213
19,046.1147

Derived: shares × price per share. Exact value 19046.1147.

516,775Direct (D) No
F1, F2
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
  • F2 The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.11 to $5.1301, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0000905148-26-001380 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,8165.245
14,769.92

Derived: shares × price per share. Exact value 14769.920.

190,312Direct (D) No
F1
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
Open filing 0000905148-26-001382 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18SCHACHLE JOSEPH K Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,7195.2501
19,525.1219

Derived: shares × price per share. Exact value 19525.1219.

300,781Direct (D) No
F1
  • F1 The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
Open filing 0000905148-26-001384 Read from the filing’s XML Dispute this row
2026-02-12 Filed 2026-02-17Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc.
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,3133.39
18,011.07

Derived: shares × price per share. Exact value 18011.07.

520,494Direct (D) No
F1
  • F1 The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities.
Open filing 0000905148-26-000904 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-26Gagnon Robert E. Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)400,0000—600,000Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.
Open filing 0000905148-26-000354 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-26YERXA BENJAMIN R Director · Officer: President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)400,0000—719,005Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.
Open filing 0000905148-26-000359 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-26Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)400,0000—525,807Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.
Open filing 0000905148-26-000355 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-26SCHACHLE JOSEPH K Officer: Chief Operating Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)250,0000—304,500Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.
Open filing 0000905148-26-000358 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-26Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)86,5000—193,128Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.
Open filing 0000905148-26-000357 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-01-26Magrath George Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)483,6390—1,775,293Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.
Open filing 0000905148-26-000356 Read from the filing’s XML Dispute this row
2026-01-18 Filed 2026-01-21Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,3902.1
7,119

Derived: shares × price per share. Exact value 7119.0.

106,628Direct (D) No
F1
  • F1 The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities.
Open filing 0000905148-26-000282 Read from the filing’s XML Dispute this row
2026-01-10 Filed 2026-01-13Zaremba Rabourn Amy Officer: Head of Fin. Quality Assurance
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,9501.93
7,623.5

Derived: shares × price per share. Exact value 7623.50.

110,018Direct (D) No
F1
  • F1 The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities.
Open filing 0000905148-26-000164 Read from the filing’s XML Dispute this row
2026-01-06 Filed 2026-01-08Gallagher Cam Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)67,0000—1,991,430Direct (D) No
F1
  • F1 Represents a grant of restricted stock units which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date.
Open filing 0000905148-26-000088 Read from the filing’s XML Dispute this row
2026-01-01 Filed 2026-01-05Bennett Jean Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,127——234,652Direct (D) No
F1
  • F1 The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date.
Open filing 0000905148-26-000028 Read from the filing’s XML Dispute this row
2026-01-01 Filed 2026-01-05Ainsworth Sean Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)42,507——297,325Direct (D) No
F1
  • F1 The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date.
Open filing 0000905148-26-000027 Read from the filing’s XML Dispute this row
2026-01-01 Filed 2026-01-05MANUSO JAMES S J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)31,188——292,951Direct (D) No
F1
  • F1 The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date.
Open filing 0000905148-26-000036 Read from the filing’s XML Dispute this row
2026-01-01 Filed 2026-01-05Graves Adrienne L Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)23,643——103,147Direct (D) No
F1
  • F1 The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date.
Open filing 0000905148-26-000031 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2025-12-31Gallagher Cam Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)33,0000—1,924,430Direct (D) No
F4, F5
  • F4 Represents a grant of restricted stock units (RSUs) which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date.
  • F5 On December 31, 2025, the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 6, 2026, of an additional 67,000 RSUs which vest on December 29, 2026, subject to the Reporting Person's continuing service through the vesting date.
Open filing 0000905148-25-004511 Read from the filing’s XML Dispute this row

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
Ainsworth Sean DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock79,592D As of 2025-04-30 Open filing 4
Ainsworth Sean DirectorCommon Stock 321,692D As of 2026-04-20 Open filing 4
Bennett Jean DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock79,592D As of 2025-04-30 Open filing 4
Bennett Jean DirectorCommon Stock 259,019D As of 2026-04-20 Open filing 4
Benton Susan DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock79,592D As of 2025-04-30 Open filing 4
Benton Susan DirectorCommon Stock 243,894D As of 2026-04-20 Open filing 4
Foundation Fighting Blindness Retinal Degeneration Fund Director · 10% owner · Other: See RemarksSeries A Non-Voting Convertible Preferred Stock Derivative security · underlying Common Stock0D As of 2025-05-05 Open filing 4
Foundation Fighting Blindness Retinal Degeneration Fund Director · Other: See RemarksCommon Stock 3,236,171D As of 2026-09-30 Open filing 4
Foundation Fighting Blindness, Inc. Director · 10% owner · Other: See RemarksSeries A Non-Voting Convertible Preferred Stock Derivative security · underlying Common Stock0D As of 2025-05-05 Open filing 4
Foundation Fighting Blindness, Inc. Director · Other: See RemarksCommon Stock 3,236,171D As of 2026-09-30 Open filing 4
Gagnon Robert E. Officer: Chief Financial OfficerEmployee Stock Option (right to buy) Derivative security · underlying Common Stock250,000D As of 2025-09-02 Open filing 4
Gagnon Robert E. Officer: Chief Financial OfficerCommon Stock 542,375D As of 2026-10-23 Open filing 4
Gallagher Cam DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock79,592D As of 2025-04-30 Open filing 4
Gallagher Cam DirectorWarrant (right to buy) Derivative security · underlying Common Stock0D As of 2026-09-08 Open filing 4
Gallagher Cam DirectorWarrants (right to buy) Derivative security · underlying Common Stock784,314D As of 2025-03-24 Open filing 4
Gallagher Cam DirectorCommon Stock 83,000I By Garret Gallagher - Custodian UTMA/UGMAAs of 2026-09-08 Open filing 4
Gallagher Cam DirectorCommon Stock 2,800,111D As of 2026-09-08 Open filing 4
Gallagher Cam DirectorCommon Stock 83,000I By Garret Gallagher - Custodian UTMA/UGMAAs of 2025-12-29 Open filing 4
Graves Adrienne L DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock79,592D As of 2025-04-30 Open filing 4
Graves Adrienne L DirectorCommon Stock 127,514D As of 2026-04-20 Open filing 4
Hoffmann Bernhard Officer: SVP of Corp. Dev.Employee Stock Option (right to buy) Derivative security · underlying Common Stock29,500D As of 2025-03-13 Open filing 4
Hoffmann Bernhard Officer: SVP of Corp. Dev.Common Stock 185,446D As of 2025-03-13 Open filing 4
Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc.Employee Stock Option (right to buy) Derivative security · underlying Common Stock52,500D As of 2025-03-13 Open filing 4
Jayagopal Ashwath Officer: Chief Scientific Dev. Ofc.Common Stock 509,233D As of 2026-04-23 Open filing 4
Jhaveri Nirav S. Officer: Chief Financial OfficerEmployee Stock Option (right to buy) Derivative security · underlying Common Stock52,500D As of 2025-03-13 Open filing 4
Jhaveri Nirav S. Officer: Chief Financial OfficerCommon Stock 194,293D As of 2025-03-13 Open filing 4
MANUSO JAMES S J DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock79,592D As of 2025-04-30 Open filing 4
MANUSO JAMES S J DirectorCommon Stock 317,318D As of 2026-04-20 Open filing 4
Magrath George Officer: Chief Executive OfficerEmployee Stock Option (right to buy) Derivative security · underlying Common Stock330,697D As of 2025-03-13 Open filing 4
Magrath George Director · Officer: Chief Executive OfficerWarrant (right to buy) Derivative security · underlying Common Stock0D As of 2026-09-09 Open filing 4
Magrath George Director · Officer: Chief Executive OfficerWarrants (right to buy) Derivative security · underlying Common Stock392,157D As of 2025-03-24 Open filing 4
Magrath George Director · Officer: Chief Executive OfficerCommon Stock 2,010,636D As of 2026-11-03 Open filing 4
Rodgers Richard J DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock79,592D As of 2025-04-30 Open filing 4
Rodgers Richard J DirectorCommon Stock 343,022D As of 2026-04-20 Open filing 4
SCHACHLE JOSEPH K Officer: Chief Operating OfficerEmployee Stock Option (right to buy) Derivative security · underlying Common Stock52,500D As of 2025-03-13 Open filing 4
SCHACHLE JOSEPH K Officer: Chief Operating OfficerCommon Stock 286,673D As of 2026-10-23 Open filing 4
YERXA BENJAMIN R Director · Officer: PresidentCommon Stock 670,917D As of 2026-10-23 Open filing 4
Zaremba Rabourn Amy Officer: SVP of FinanceEmployee Stock Option (right to buy) Derivative security · underlying Common Stock39,500D As of 2025-03-13 Open filing 4
Zaremba Rabourn Amy Officer: Head of Fin. Quality AssuranceCommon Stock 188,671D As of 2026-04-23 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 123

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
PERCEPTIVE ADVISORS LLC 9,000,000 SH43,560,000 dollarsNot in the prior quarter’s filings read Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row
Caligan Partners LP 5,960,972 SH28,851,104 dollarsLower by 116,112 Prior quarter: 6,077,084Open filing 0001420506-26-002879 Filed 2026-11-16 Dispute this row
Cormorant Asset Management, LP Partly reported under another manager5,500,000 SH26,620,000 dollarsNot in the prior quarter’s filings read Open filing 0001583977-26-000011 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager5,236,178 SH25,343,101 dollarsHigher by 2,119,691 Prior quarter: 3,116,487Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Nantahala Capital Management, LLC 4,569,528 SH22,116,516 dollarsLower by 1,553,190 Prior quarter: 6,122,718Open filing 0001104659-26-127125 Filed 2026-11-13 Dispute this row
Boxer Capital Management, LLC 4,533,660 SH21,942,914 dollarsHigher by 1,718,660 Prior quarter: 2,815,000Open filing 0001213900-26-120704 Filed 2026-11-16 Dispute this row
Balyasny Asset Management L.P. 3,728,638 SH18,046,608 dollarsHigher by 640,772 Prior quarter: 3,087,866Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row
BIOS Capital Management, LP Partly reported under another manager3,683,429 SH17,827,796 dollarsUnchanged Prior quarter: 3,683,429Open filing 0001813845-26-000009 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 3,273,451 SH15,843,503 dollarsHigher by 314,768 Prior quarter: 2,958,683Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager3,161,606 SH15,302,172 dollarsHigher by 1,215,997 Prior quarter: 1,945,609Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
MILLENNIUM MANAGEMENT LLC 3,136,021 SH15,178,342 dollarsHigher by 833,920 Prior quarter: 2,302,101Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
Trails Edge Capital Partners, LP 2,411,657 SH11,672,420 dollarsLower by 332,001 Prior quarter: 2,743,658Open filing 0002077247-26-000005 Filed 2026-11-16 Dispute this row
ADAGE CAPITAL PARTNERS GP, L.L.C. 2,254,996 SH10,914,181 dollarsLower by 3,774,779 Prior quarter: 6,029,775Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,810,968 SH8,767,030 dollarsHigher by 443,256 Prior quarter: 1,367,712Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
ADAR1 Capital Management, LLC 1,783,781 SH8,633,500 dollarsUnchanged Prior quarter: 1,783,781Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager1,330,398 SH6,439,126 dollarsHigher by 540,262 Prior quarter: 790,136Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
BOOTHBAY FUND MANAGEMENT, LLC 1,166,787 SH5,647,249 dollarsLower by 22,728 Prior quarter: 1,189,515Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row
AWM Investment Company, Inc. 1,051,936 SH5,091,370 dollarsHigher by 819,346 Prior quarter: 232,590Open filing 0001535264-26-000061 Filed 2026-11-13 Dispute this row
Logos Global Management LP 1,000,000 SH4,840,000 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005476 Filed 2026-11-19 Dispute this row
Blue Owl Capital Holdings LP Partly reported under another manager969,605 SH4,692,888 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-459653 Filed 2026-11-13 Dispute this row
Affinity Asset Advisors, LLC 900,000 SH4,356,000 dollarsNot in the prior quarter’s filings read Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager877,876 SH4,248,920 dollarsLower by 649,353 Prior quarter: 1,527,229Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
GREAT POINT PARTNERS LLC Partly reported under another manager776,881 SH3,760,104 dollarsLower by 1,193,306 Prior quarter: 1,970,187Open filing 0001172661-26-005345 Filed 2026-11-16 Dispute this row
Opaleye Management Inc. 750,000 SH3,630,000 dollarsLower by 375,000 Prior quarter: 1,125,000Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 734,419 SH3,554,588 dollarsHigher by 362,469 Prior quarter: 371,950Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager723,459 SH3,501,542 dollarsHigher by 39,564 Prior quarter: 683,895Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Woodline Partners LP 661,729 SH3,202,768 dollarsLower by 772,984 Prior quarter: 1,434,713Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager560,304 SH2,711,871 dollarsHigher by 118,150 Prior quarter: 442,154Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 538,986 SH2,608,692 dollarsHigher by 128,611 Prior quarter: 410,375Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
ACUTA CAPITAL PARTNERS, LLC 514,110 SH2,488,292 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-127905 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC 497,481 SH2,407,808 dollarsLower by 168,181 Prior quarter: 665,662Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Squarepoint Ops LLC Partly reported under another manager352,924 SH1,708,152 dollarsHigher by 22,141 Prior quarter: 330,783Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager350,141 SH1,694,682 dollarsHigher by 153,244 Prior quarter: 196,897Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
XTX Topco Ltd Partly reported under another manager287,409 SH1,391,060 dollarsHigher by 143,314 Prior quarter: 144,095Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
Propel Bio Management, LLC Partly reported under another manager270,036 SH1,306,974 dollarsNot in the prior quarter’s filings read Open filing 0001829126-26-012373 Filed 2026-11-13 Dispute this row
Aureus Asset Management, LLC 265,729 SH1,286,128 dollarsHigher by 207,529 Prior quarter: 58,200Open filing 0001398344-26-020036 Filed 2026-11-13 Dispute this row
Bleichroeder LP 236,842 SH1,146,315 dollarsLower by 500,000 Prior quarter: 736,842Open filing 0001420506-26-002662 Filed 2026-11-13 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 204,178 SH988,222 dollarsHigher by 39,125 Prior quarter: 165,053Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager162,665 SH787,298 dollarsLower by 302,235 Prior quarter: 464,900Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager151,289 SH732,240 dollarsHigher by 28,810 Prior quarter: 122,479Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Informed Momentum Co LLC 145,687 SH705,125 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-127619 Filed 2026-11-16 Dispute this row
TWO SIGMA INVESTMENTS, LP 133,632 SH646,779 dollarsLower by 120,330 Prior quarter: 253,962Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager129,404 SH626,315 dollarsHigher by 129,262 Prior quarter: 142Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Creative Planning 128,869 SH623,726 dollarsHigher by 503 Prior quarter: 128,366Open filing 0001540235-26-000006 Filed 2026-11-02 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager120,630 SH583,849 dollarsNot in the prior quarter’s filings read Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
Texas Capital Bank Wealth Management Services Inc 117,000 SH566,280 dollarsLower by 5,529 Prior quarter: 122,529Open filing 0001802655-26-000009 Filed 2026-11-09 Dispute this row
Nuveen, LLC Partly reported under another manager115,361 SH558,348 dollarsHigher by 44,018 Prior quarter: 71,343Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager108,949 SH527,313 dollarsHigher by 53,944 Prior quarter: 55,005Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
SEI INVESTMENTS CO Partly reported under another manager105,414 SH510,204 dollarsNot in the prior quarter’s filings read Open filing 0000350894-26-000059 Filed 2026-11-10 Dispute this row
Stonepine Capital Management, LLC 98,147 SH475,031 dollarsLower by 2,571 Prior quarter: 100,718Open filing 0001440771-26-000027 Filed 2026-11-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • SummitTX Capital, L.P. 1,007,351 SH
  • JANE STREET GROUP, LLC 188,988 SH
  • Sixth Street Partners Management Company, L.P. 165,053 SH
  • Mink Brook Asset Management LLC 161,205 SH
  • Jump Financial, LLC 94,820 SH
  • EntryPoint Capital, LLC 50,883 SH
  • Empowered Funds, LLC 42,065 SH
  • BRIDGEWAY CAPITAL MANAGEMENT, LLC 42,065 SH
  • MANGROVE PARTNERS IM, LLC 41,717 SH
  • Point72 Asset Management, L.P. 18,922 SH
  • KESTRA PRIVATE WEALTH SERVICES, LLC 12,800 SH
  • STONERIDGE INVESTMENT PARTNERS LLC 12,695 SH
  • Engineers Gate Manager LP 12,063 SH
  • INTECH INVESTMENT MANAGEMENT LLC 11,566 SH
  • STRS OHIO 10,500 SH
  • TD Waterhouse Canada Inc. 3,000 SH
  • GGM Financial LLC 1,005 SH
  • INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 521 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Institutional ownership reported on Form 13F

13F filers report holding between 45.64% and 80.54% of shares outstanding.

Quarter ending 2026-09-30, against 96,654,336 shares on the cover dated 2026-11-06.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 11444,114,47877,847,6948,935
2026-06-30 10437,280,49360,803,4289,178
2026-03-31 7930,395,69745,424,2319,173
2025-12-31 5919,609,11327,812,3689,222
2025-09-30 4812,728,72019,036,3048,469
2025-06-30 4411,709,26717,630,4518,516
2025-03-31 4711,166,78614,560,3168,518
2024-12-31 44505,0493,678,8768,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Cormorant Asset Management, LP Common Stock, par value $0.0001 per share6.615,500,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13GOpen filing 0001172661-26-005298 Dispute this row
Bihua Chen Common Stock, par value $0.0001 per share6.615,500,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13GOpen filing 0001172661-26-005298 Dispute this row
Caligan Partners LP Common Stock, $0.0001 par value per share6.25,960,972.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001727492-26-000027 Dispute this row
JOHNSON DAVID EDWARD Common Stock, $0.0001 par value per share6.25,960,972.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001727492-26-000027 Dispute this row
BALYASNY ASSET MANAGEMENT L.P. Common Stock7.366,120,982.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 3Open filing 0001172661-26-005045 Dispute this row
BAM GP LLC Common Stock7.366,120,982.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 3Open filing 0001172661-26-005045 Dispute this row
Balyasny Asset Management Holdings LP Common Stock7.366,120,982.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 3Open filing 0001172661-26-005045 Dispute this row
Dames GP LLC Common Stock7.366,120,982.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 3Open filing 0001172661-26-005045 Dispute this row
Dmitry Balyasny Common Stock7.366,120,982.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 3Open filing 0001172661-26-005045 Dispute this row
Perceptive Advisors LLC Common Stock, $0.0001 par value per share9.9910,086,52509/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-463810 Dispute this row
Joseph Edelman Common Stock, $0.0001 par value per share9.9910,086,52509/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-463810 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 par value per share9.9910,086,52509/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-463810 Dispute this row
Boxer Capital Management, LLC Common Stock, $0.0001 par value per share5.44,533,660.0009/30/2026 Filed 2026-11-16SCHEDULE 13GOpen filing 0001213900-26-120703 Dispute this row
Boxer Holdings, LP Common Stock, $0.0001 par value per share5.44,533,660.0009/30/2026 Filed 2026-11-16SCHEDULE 13GOpen filing 0001213900-26-120703 Dispute this row
Boxer Holdings GP, LLC Common Stock, $0.0001 par value per share5.44,533,660.0009/30/2026 Filed 2026-11-16SCHEDULE 13GOpen filing 0001213900-26-120703 Dispute this row
Aaron Davis Common Stock, $0.0001 par value per share5.44,533,660.0009/30/2026 Filed 2026-11-16SCHEDULE 13GOpen filing 0001213900-26-120703 Dispute this row
Adage Capital Management, L.P. Common Stock, par value $0.0001 per share2.712,254,996.0009/30/2026 Filed 2026-11-12SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-007560 Dispute this row
Robert Atchinson Common Stock, par value $0.0001 per share2.712,254,996.0009/30/2026 Filed 2026-11-12SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-007560 Dispute this row
Phillip Gross Common Stock, par value $0.0001 per share2.712,254,996.0009/30/2026 Filed 2026-11-12SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-007560 Dispute this row
BlackRock, Inc. Common Stock6.15,044,84709/30/2026 Filed 2026-10-27SCHEDULE 13GOpen filing 0002012383-26-003823 Dispute this row
Perceptive Advisors LLC Common Stock, $0.0001 par value per share9.999,233,71006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0001193125-26-352641 Dispute this row
Joseph Edelman Common Stock, $0.0001 par value per share9.999,233,71006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0001193125-26-352641 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 par value per share9.999,233,71006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0001193125-26-352641 Dispute this row
BALYASNY ASSET MANAGEMENT L.P. Common Stock6.645,480,210.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-003425 Dispute this row
BAM GP LLC Common Stock6.645,480,210.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-003425 Dispute this row
Balyasny Asset Management Holdings LP Common Stock6.645,480,210.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-003425 Dispute this row
Dames GP LLC Common Stock6.645,480,210.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-003425 Dispute this row
Dmitry Balyasny Common Stock6.645,480,210.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-26-003425 Dispute this row
Caligan Partners LP Common Stock, $0.0001 par value per share7.36,077,084.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001727492-26-000020 Dispute this row
JOHNSON DAVID EDWARD Common Stock, $0.0001 par value per share7.36,077,084.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001727492-26-000020 Dispute this row
Foundation Fighting Blindness Retinal Degeneration Fund Common Stock, $0.0001 par value per share4.663,792,17105/18/2026 Filed 2026-05-20SCHEDULE 13D/AAmendment 3Open filing 0001193125-26-233062 Dispute this row
Foundation Fighting Blindness, Inc. Common Stock, $0.0001 par value per share4.663,792,17105/18/2026 Filed 2026-05-20SCHEDULE 13D/AAmendment 3Open filing 0001193125-26-233062 Dispute this row
AARON G.L. FLETCHER Common Stock, $0.0001 par value per share4.533,683,42905/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
BIOS ADVISORS GP, LLC Common Stock, $0.0001 par value per share4.533,683,42905/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
BIOS CAPITAL MANAGEMENT, LP Common Stock, $0.0001 par value per share4.533,683,42905/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
BIOS EQUITY PARTNERS III, LP Common Stock, $0.0001 par value per share4.533,683,42905/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
BIOS FUND III, LP Common Stock, $0.0001 par value per share0.53430,66505/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
BIOS FUND III NT, LP Common Stock, $0.0001 par value per share0.55450,81105/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
BIOS FUND III QP, LP Common Stock, $0.0001 par value per share3.442,801,95305/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
CAVU ADVISORS, LLC Common Stock, $0.0001 par value per share4.533,683,42905/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
CAVU MANAGEMENT, LP Common Stock, $0.0001 par value per share4.533,683,42905/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
LESLIE W. KREIS Common Stock, $0.0001 par value per share4.533,683,42905/12/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0001791917-26-000005 Dispute this row
Perceptive Advisors LLC Common Stock, $0.0001 par value per share9.998,830,14503/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-226555 Dispute this row
Joseph Edelman Common Stock, $0.0001 par value per share9.998,830,14503/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-226555 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.0001 par value per share9.998,830,14503/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-226555 Dispute this row
Caligan Partners LP Common Stock, $0.0001 par value per share8.56,075,028.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001727492-26-000010 Dispute this row
JOHNSON DAVID EDWARD Common Stock, $0.0001 par value per share8.56,075,028.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001727492-26-000010 Dispute this row
Nantahala Capital Management, LLC Common Stock, $0.0001 par value per share6.514,839,225.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 3Open filing 0001104659-26-062694 Dispute this row
Wilmot B. Harkey Common Stock, $0.0001 par value per share6.514,839,225.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 3Open filing 0001104659-26-062694 Dispute this row
Daniel Mack Common Stock, $0.0001 par value per share6.514,839,225.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 3Open filing 0001104659-26-062694 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015258,595
2016246,472
2017244,814
2018245,575
2019238,619
2020249,093
2021274,850
2022257,922
2023253,676
2024261,106
2025235,525
2026263,830

Filings made before the SEC required XML are listed, not extracted.

Back to Opus Genetics, Inc.